• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同年龄段患者接受复杂高危经皮冠状动脉介入治疗类型、趋势及院内结局:来自全国注册登记研究的分析。

Complex, high-risk percutaneous coronary intervention types, trends, and in-hospital outcomes among different age groups: An insight from a national registry.

机构信息

Keele Cardiovascular Research Group, Centre for Prognosis Research, Institutes of Applied Clinical Science and Primary Care and Health Sciences, Keele University, Stoke-on-Trent, UK.

Royal Stoke University Hospital, Stoke-on-Trent, UK.

出版信息

Catheter Cardiovasc Interv. 2022 Nov;100(5):711-720. doi: 10.1002/ccd.30366. Epub 2022 Sep 2.

DOI:10.1002/ccd.30366
PMID:36054239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9826050/
Abstract

BACKGROUND

Complex, high-risk percutaneous coronary intervention (PCI) (CHiP) is increasingly being undertaken in octogenarians. However, limited data exist on CHiP types, trends, and outcomes in the octogenarian.

METHODS

This is a retrospective cohort study from a national registry dataset on CHiP undertaken in patients with stable angina in England and Wales (January 2006 and December 2017) according to three age groups (group 1 [G1]: < 65 years; group 2 [G2]: 65-79 years; and group 3 [G3]: ≥80 years).

RESULTS

Of 424,290 elective PCI procedures, 138,831 (33.0%) were CHiP [G1: 46,832 (33.7%); G2: 59,544 (42.9%); G3: 32,455 (23.4%)]. Among CHiP types, chronic total occlusion (CTO) (49.2%), prior coronary artery bypass graft (CABG) (30.4%), and severe vascular calcification (21.8%) were common in G1; prior CABG (42.9%), CTO (32.9%), and severe vascular calcifications (27%) were common in G2; prior CABG (15.8%), severe vascular calcification (15.5%), and chronic renal failure (11.1%) were common CHiP among the octogenarians. The older age groups had higher adjusted odds (aOR) for adverse outcomes [G2: mortality, aOR 1.7, 95% confidence interval (CI): (1.3-2.3); major bleeding, aOR 1.3, 95% CI (1.1-1.5); MACCE, aOR 1.2, 95% CI (1.0-1.3); G3: mortality, aOR 2.6, 95%CI (1.9-3.6); major bleeding, aOR 1.4, 95% CI (1.1-1.7); MACCE, aOR 1.3, 95% CI (1.1-1.5)].

CONCLUSION

There were significant differences in the types of CHiP cases undertaken and clinical outcomes across age groups.

摘要

背景

复杂、高危经皮冠状动脉介入治疗(PCI)(CHiP)在 80 岁以上患者中越来越常见。然而,关于 80 岁以上患者的 CHiP 类型、趋势和结果的数据有限。

方法

这是一项回顾性队列研究,来自英国和威尔士的全国性 CHiP 登记数据集(2006 年 1 月至 2017 年 12 月),根据年龄分为三组(第 1 组 [G1]:<65 岁;第 2 组 [G2]:65-79 岁;第 3 组 [G3]:≥80 岁)。

结果

在 424290 例选择性 PCI 手术中,138831 例(33.0%)为 CHiP [G1:46832 例(33.7%);G2:59544 例(42.9%);G3:32455 例(23.4%)]。在 CHiP 类型中,慢性完全闭塞(CTO)(49.2%)、既往冠状动脉旁路移植术(CABG)(30.4%)和严重血管钙化(21.8%)在 G1 中常见;既往 CABG(42.9%)、CTO(32.9%)和严重血管钙化(27%)在 G2 中常见;既往 CABG(15.8%)、严重血管钙化(15.5%)和慢性肾功能衰竭(11.1%)在 80 岁以上患者中常见。年龄较大的组发生不良结局的调整比值比(aOR)更高[G2:死亡率,aOR 1.7,95%置信区间(CI):(1.3-2.3);大出血,aOR 1.3,95%CI(1.1-1.5);MACCE,aOR 1.2,95%CI(1.0-1.3);G3:死亡率,aOR 2.6,95%CI(1.9-3.6);大出血,aOR 1.4,95%CI(1.1-1.7);MACCE,aOR 1.3,95%CI(1.1-1.5)]。

结论

不同年龄组的 CHiP 病例类型和临床结局存在显著差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a890/9826050/1e0ddc80efb3/CCD-100-711-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a890/9826050/bd6fd5ecc93f/CCD-100-711-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a890/9826050/eead56fd71c8/CCD-100-711-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a890/9826050/1e0ddc80efb3/CCD-100-711-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a890/9826050/bd6fd5ecc93f/CCD-100-711-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a890/9826050/eead56fd71c8/CCD-100-711-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a890/9826050/1e0ddc80efb3/CCD-100-711-g003.jpg

相似文献

1
Complex, high-risk percutaneous coronary intervention types, trends, and in-hospital outcomes among different age groups: An insight from a national registry.不同年龄段患者接受复杂高危经皮冠状动脉介入治疗类型、趋势及院内结局:来自全国注册登记研究的分析。
Catheter Cardiovasc Interv. 2022 Nov;100(5):711-720. doi: 10.1002/ccd.30366. Epub 2022 Sep 2.
2
Sex differences in high-risk but indicated coronary interventions (CHiP): National report from British Cardiovascular Intervention Society Registry.高危但有指征的冠状动脉介入治疗(CHiP)中的性别差异:英国心血管介入学会注册中心的国家报告。
Catheter Cardiovasc Interv. 2022 Feb;99(2):447-456. doi: 10.1002/ccd.30081. Epub 2022 Jan 18.
3
Complex high-risk percutaneous coronary intervention types, trends, and outcomes according to vascular access site.根据血管入路部位的复杂高风险经皮冠状动脉介入治疗类型、趋势及结果
Catheter Cardiovasc Interv. 2023 Nov;102(5):803-813. doi: 10.1002/ccd.30846. Epub 2023 Sep 26.
4
Ethnicity in Complex High-Risk but Indicated Percutaneous Coronary Intervention Types and Outcomes.复杂高危但有指征的经皮冠状动脉介入治疗类型与结局的种族差异。
Am J Cardiol. 2022 Jul 15;175:26-37. doi: 10.1016/j.amjcard.2022.03.056. Epub 2022 May 14.
5
Complex High-Risk Percutaneous Coronary Intervention Types, Trends, and Outcomes in Nonsurgical Centres.非外科中心复杂高危经皮冠状动脉介入治疗类型、趋势和结果。
Can J Cardiol. 2024 Jul;40(7):1237-1246. doi: 10.1016/j.cjca.2024.01.003. Epub 2024 Jan 11.
6
Complex high-risk and indicated percutaneous coronary intervention for stable angina: Does operator volume influence patient outcome?复杂高危和指征性经皮冠状动脉介入治疗稳定型心绞痛:术者手术量是否影响患者预后?
Am Heart J. 2020 Apr;222:15-25. doi: 10.1016/j.ahj.2019.12.019. Epub 2020 Jan 7.
7
Clinical outcomes of percutaneous coronary intervention for chronic total occlusion in prior coronary artery bypass grafting patients.经皮冠状动脉介入治疗在既往冠状动脉旁路移植术患者中的慢性完全闭塞的临床结局。
Catheter Cardiovasc Interv. 2022 Jan 1;99(1):74-84. doi: 10.1002/ccd.29691. Epub 2021 May 4.
8
Percutaneous Coronary Intervention in Native Coronary Arteries Versus Bypass Grafts in Patients With Prior Coronary Artery Bypass Graft Surgery: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.经皮冠状动脉介入治疗在既往冠状动脉旁路移植术患者中的应用:来自退伍军人事务部临床评估、报告和跟踪计划的见解。
JACC Cardiovasc Interv. 2016 May 9;9(9):884-93. doi: 10.1016/j.jcin.2016.01.034. Epub 2016 Apr 13.
9
Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG).伴有非ST段抬高型心肌梗死的糖尿病合并多支冠状动脉疾病患者的血运重建趋势:来自国家心血管数据注册库急性冠状动脉治疗和干预结果网络注册库-遵循指南行动(NCDR ACTION注册库-GWTG)的见解
Circ Cardiovasc Qual Outcomes. 2016 May;9(3):197-205. doi: 10.1161/CIRCOUTCOMES.115.002084. Epub 2016 May 10.
10
Prior Coronary Artery Bypass Graft Surgery and Outcome After Percutaneous Coronary Intervention: An Observational Study From the Pan-London Percutaneous Coronary Intervention Registry.经皮冠状动脉介入治疗前冠状动脉旁路移植术和经皮冠状动脉介入治疗后的结果:来自泛伦敦经皮冠状动脉介入治疗登记处的观察性研究。
J Am Heart Assoc. 2020 Jun 16;9(12):e014409. doi: 10.1161/JAHA.119.014409. Epub 2020 Jun 1.

引用本文的文献

1
Application of Drug-Coated Balloons in Complex High Risk and Indicated Percutaneous Coronary Interventions.药物涂层球囊在复杂高危及特定经皮冠状动脉介入治疗中的应用
Catheter Cardiovasc Interv. 2025 Feb;105(2):494-516. doi: 10.1002/ccd.31316. Epub 2024 Dec 11.
2
Complex and high-risk intervention in indicated patients (CHIP) in contemporary clinical practice.当代临床实践中的有指征患者的复杂高风险干预(CHIP)。
Cardiovasc Interv Ther. 2023 Jul;38(3):269-274. doi: 10.1007/s12928-023-00930-1. Epub 2023 Mar 27.

本文引用的文献

1
Ethnicity in Complex High-Risk but Indicated Percutaneous Coronary Intervention Types and Outcomes.复杂高危但有指征的经皮冠状动脉介入治疗类型与结局的种族差异。
Am J Cardiol. 2022 Jul 15;175:26-37. doi: 10.1016/j.amjcard.2022.03.056. Epub 2022 May 14.
2
Sex differences in high-risk but indicated coronary interventions (CHiP): National report from British Cardiovascular Intervention Society Registry.高危但有指征的冠状动脉介入治疗(CHiP)中的性别差异:英国心血管介入学会注册中心的国家报告。
Catheter Cardiovasc Interv. 2022 Feb;99(2):447-456. doi: 10.1002/ccd.30081. Epub 2022 Jan 18.
3
Age-Stratified Outcome in Treatment of Left Main Coronary Artery Stenosis: A NOBLE Trial Substudy.
左主干冠状动脉狭窄治疗的年龄分层结果:NOBLE 试验亚研究。
Cardiology. 2021;146(4):409-418. doi: 10.1159/000515376. Epub 2021 Apr 13.
4
Revascularisation strategies in patients with significant left main coronary disease during the COVID-19 pandemic.COVID-19 大流行期间,左主干病变患者的血运重建策略。
Catheter Cardiovasc Interv. 2021 Dec 1;98(7):1252-1261. doi: 10.1002/ccd.29663. Epub 2021 Mar 25.
5
A Novel Risk Score to Predict One-Year Mortality in Patients Undergoing Complex High-Risk Indicated Percutaneous Coronary Intervention (CHIP-PCI).一项预测行复杂高危指征性经皮冠状动脉介入治疗(CHIP-PCI)患者一年死亡率的新型风险评分。
J Invasive Cardiol. 2021 Apr;33(4):E253-E258. doi: 10.25270/jic/20.00515. Epub 2021 Feb 4.
6
Percutaneous coronary intervention in octogenarians: A risk scoring system to predict 30-day outcomes in the elderly.老年患者的经皮冠状动脉介入治疗:一种预测老年人30天预后的风险评分系统。
Catheter Cardiovasc Interv. 2021 Dec 1;98(7):1300-1307. doi: 10.1002/ccd.29406. Epub 2020 Dec 6.
7
Clinical Outcomes of Percutaneous Coronary Intervention for Chronic Total Occlusion in Native Coronary Arteries vs Saphenous Vein Grafts.经皮冠状动脉介入治疗在治疗原生冠状动脉与隐静脉桥血管慢性完全闭塞病变中的临床疗效比较。
J Invasive Cardiol. 2020 Sep;32(9):350-357. doi: 10.25270/jic/20.00180. Epub 2020 Aug 10.
8
Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients.当代经皮冠状动脉介入治疗患者中学术研究联盟高出血风险定义的验证。
J Am Coll Cardiol. 2020 Jun 2;75(21):2711-2722. doi: 10.1016/j.jacc.2020.03.070.
9
SCAI position statement on optimal percutaneous coronary interventional therapy for complex coronary artery disease.SCAI关于复杂冠状动脉疾病最佳经皮冠状动脉介入治疗的立场声明。
Catheter Cardiovasc Interv. 2020 Aug;96(2):346-362. doi: 10.1002/ccd.28994. Epub 2020 Jun 4.
10
Comparison of long-term outcomes of medical therapy and successful recanalisation for coronary chronic total occlusions in elderly patients: a report of 1,294 patients.老年患者冠状动脉慢性完全闭塞病变药物治疗与成功再通的长期预后比较:1294例患者的报告
Cardiovasc Diagn Ther. 2019 Dec;9(6):586-595. doi: 10.21037/cdt.2019.11.01.